Genmab's 109-patient RAINFOL-01 cohort had a 12.1-month median response duration; the uncontrolled result now feeds a Phase 3 ...

Congress delayed the 0.4-milligram per-container hemp threshold to Dec. 11; Tilray's dated releases list 5mg and 10mg U.S.

Evergold's Oct. 2 Golden Lion results include 4.9 metres at 7.70 g/t gold and 186 g/t silver; assays from ten holes remain ...

Novo Nordisk says facility remediation extended the FDA's denecimig review beyond Q3 2026, with no new action date yet.

Bitdeer says it mined and sold 292.3 BTC through Oct. 2, leaving zero pure holdings; its weekly post gives no proceeds or ...

WISeSat.Space began Nasdaq trading on Oct. 2 as SAIQ after its Oct. 1 Columbus merger; the closing notices omit WISeQey's ...

NRC issued TVA a permit Sept. 28 to construct one 300 MW BWRX-300 at Clinch River; GE Vernova's Sept. 29 release gives no equipment price.

AYR transferred certain Ohio operations to a noteholder buyer on Oct. 1 after state approvals, without disclosing proceeds or ...

Argentina admits Glencore's US$4B MARA copper plan to RIGI; Alumbrera now targets first production in the second half of 2027 ...

Surge Battery Metals' Oct. 2 Nevada North PFS estimates US$9.81B in after-tax NPV and US$2.77B in first-phase capital.

Ultragenyx said the EMA validated its MPS IIIA gene therapy filing on Oct. 2, allowing scientific review to begin; no EU ...

Selkirk Copper reported 5.4 metres at 9.27 per cent copper in a Minto North step-out; Phase 2 assays were excluded from its ...